Analysis of the Virulence of an Atypical Enteropathogenic Escherichia coli Strain in Vitro and in Vivo and the Influence of Type Three Secretion System by Sampaio, Suely C. F. et al.
Research Article
Analysis of the Virulence of an Atypical Enteropathogenic
Escherichia coli Strain In Vitro and In Vivo and the Influence
of Type Three Secretion System
Suely C. F. Sampaio,1 Fabiana C. Moreira,1 Ana M. A. Liberatore,2 Mônica A. M. Vieira,1
Terezinha Knobl,3 Fabiano T. Romão,1 Rodrigo T. Hernandes,1,4 Claudete S. A. Ferreira,3
Antônio P. Ferreira,3 Aloísio Felipe-Silva,5 Rita Sinigaglia-Coimbra,6
Ivan H. J. Koh,2 and Tania A. T. Gomes1
1 Departamento de Microbiologia, Imunologia e Parasitologia, Universidade Federal de Sa˜o Paulo, Escola Paulista de Medicina,
Rua Botucatu 862, 3rd floor, Vila Clementino, 04023-062 Sa˜o Paulo, SP, Brazil
2 Departamento de Cirurgia, Universidade Federal de Sa˜o Paulo, Escola Paulista de Medicina, Rua Pedro de Toledo 781, 9th floor,
Vila Clementino, 04039-032 Sa˜o Paulo, SP, Brazil
3 Departamento de Ornitopatologia, Faculdade de Medicina Veterina´ria, Universidade de Sa˜o Paulo,
Avenida Prof. Dr. Orlando Marques de Paiva 87, Cidade Universita´ria, 05508-900 Sa˜o Paulo, SP, Brazil
4Departamento de Microbiologia e Imunologia, Instituto de Biocieˆncias, UNESP, Distrito de Rubia˜o Junior s/n, Botucatu,
18618-970 Sa˜o Paulo, SP, Brazil
5 Fleury Medicina e Sau´de, Avenida General Valdomiro de Lima 508, 04344-903 Sa˜o Paulo, SP, Brazil
6 Centro de Microscopia Eletroˆnica, Universidade Federal de Sa˜o Paulo, Escola Paulista de Medicina, Rua Botucatu 862,
1 st floor, 04023-062 Sa˜o Paulo, SP, Brazil
Correspondence should be addressed to Tania A. T. Gomes; tatg.amaral@unifesp.br
Received 7 February 2014; Accepted 5 April 2014; Published 28 April 2014
Academic Editor: Chensong Wan
Copyright © 2014 Suely C. F. Sampaio et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Atypical enteropathogenicEscherichia coli (aEPEC) inject various effectors into intestinal cells through a type three secretion system
(T3SS), causing attaching and effacing (A/E) lesions. We investigated the role of T3SS in the ability of the aEPEC 1711-4 strain to
interact with enterocytes in vitro (Caco-2 cells) and in vivo (rabbit ileal loops) and to translocate the rat intestinal mucosa in vivo.
A T3SS isogenic mutant strain was constructed, which showed marked reduction in the ability to associate and invade but not to
persist inside Caco-2 cells. After rabbit infection, only aEPEC 1711-4 was detected inside enterocytes at 8 and 24 hours pointing to a
T3SS-dependent invasive potential in vivo. In contrast to aEPEC 1711-4, the T3SS-deficient strain no longer produced A/E lesions or
induced macrophage infiltration. We also demonstrated that the ability of aEPEC 1711-4 to translocate through mesenteric lymph
nodes to spleen and liver in a rat model depends on a functional T3SS, since a decreased number of T3SS mutant bacteria were
recovered from extraintestinal sites.These findings indicate that the full virulence potential of aEPEC 1711-4 depends on a functional
T3SS, which contributes to efficient adhesion/invasion in vitro and in vivo and to bacterial translocation to extraintestinal sites.
1. Introduction
Atypical enteropathogenic Escherichia coli (aEPEC) are
emerging agents of diarrhea. They differ from typical EPEC
(tEPEC) strains mainly by the absence of the EAF (EPEC
adherence factor) plasmid [1, 2]. Like tEPEC, aEPEC strains
inject various effector proteins into enterocytes through a
type three secretion system (T3SS) leading to the formation of
attaching-effacing (A/E) lesions [3–5]. The assembly of T3SS
is dependent on an ATPase encoded by escN, and conse-
quently, escN mutants are incapable of assembling or inject-
ing effector proteins via T3SS into the host cell cytoplasm
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[6]. Tir (translocated intimin receptor) is a T3SS-dependent
effector protein, which is inserted in the eukaryotic cell
membrane and interacts with an EPEC outer membrane
adhesive protein (intimin) [7]. Tir-intimin interaction leads
to the establishment of A/E lesions [8]. Many other T3SS-
dependent effector proteins, such as Map (mitochondrial-
associated protein) and EspF, have important roles in aEPEC
pathogenesis. These proteins have redundant functions and
can cause epithelial barrier disruption by interacting with
tight junctions, leading to cell death by apoptosis [9, 10].
Bacterial translocation (BT) is defined as the phe-
nomenon by which live bacteria and/or their products cross
the intestinal barrier reaching normally sterile extraintestinal
sites, such as the liver, spleen, and mesenteric lymph nodes
(MLN).The translocation of certain indigenous bacteria from
the gastrointestinal tract to the MLN and various organs had
been previously demonstrated in a gnotobiotic mouse model
[11]. There is much circumstantial proof that translocation
is associated with an increased occurrence of postoperative
septic complications, and E. coli has been reported to be
one of the most common BT-associated organisms isolated
from surgical patients with postoperative sepsis [12, 13]. In
humans, one of the most well-studied translocation events is
that observed in cirrhotic patients with spontaneous bacterial
peritonitis (SBP) [14].
We recently demonstrated that an aEPEC strain (1711-
4) is able to invade and induce inflammatory responses in
intestinal Caco-2 cell lines [15]. This strain is also able to
invade these cells in vitro and to escape from the intracellular
compartment on the basolateral side [16]. In addition, we
have demonstrated that in an experimental BT-rat model,
aEPEC 1711-4 can reach the MLN, liver, and kidneys [17].
We also showed that aEPEC 1711-4 infected-animals had
intestinal mesenteric microcirculation injury and systemic
hypoperfusion similar to those observed with the virulent
murine E. coli strain R6 [17, 18]. In the BT-rat model, the
latter strain was recovered from the MLN, liver, and spleen
and impaired mesenteric microcirculation [19].
The role of T3SS-dependent effector proteins in the
ability of aEPEC to invade and persist in the intracellular
compartment in vitro and to cross the intestinal barrier in
vitro and in vivo is not yet established. The objective of this
study was to determine the role of T3SS in the ability of
aEPEC 1711-4 to invade and persist inside polarized intestinal
cells in vitro (Caco-2 cells), to promote A/E lesions and
invade in vivo (rabbit ligated ileal loop model), and to pass
through the intestinal barrier in an in vivo experimental
model (bacterial translocation model).
2. Materials and Methods
2.1. Ethics Statement. This study was carried out in strict
accordance with the recommendations of the Ethical princi-
ples of the Sociedade Brasileira de Cieˆncia em Animais de
Laborato´rio (COBEA). The protocol was approved by the
Committee on Research Ethics of the Universidade Federal
de Sa˜o Paulo (Permit number: 0235/12). All surgery was
performed under Telazol anesthesia (rabbits) or xylazine
hydrochloride plus ketamine hydrochloride (rats), and all
efforts were made to minimize suffering.
2.2. Bacterial Strains and Growth Conditions. aEPEC 1711-
4 (serotype O51:H40), which was isolated from a child
with diarrhea in the city of Sa˜o Paulo [20], an isogenic
mutant deleted in the escN gene (1711-4 ΔescN), and a
complemented mutant 1711-4 ΔescN (pEscN) were used. The
nonpathogenicE. coli strainHSwas used as a negative control
(Table 1). The strains were cultivated overnight at 37∘C in
5mL of Luria-Bertani (LB) broth. The 1711-4 ΔescN and the
1711-4 ΔescN (pEscN) strains were cultivated in LB broth
containing zeocin (60 𝜇gmL−1) and zeocin-chloramphenicol
(30 𝜇gmL−1), respectively.
2.3. Construction of an Isogenic escN Deficient Mutant of
aEPEC 1711-4 and Mutant Complementation. The escN-
deficient mutant was constructed by homologous recombi-
nation using the Lambda Red system as previously described
[15, 22]. Primers ESCN.zeo5 and ESCN.zeo3 were used to
amplify the zeocin resistance gene (Table 2). The amplified
product was electroporated into the 1711-4 strain containing
the pKOBEG-Apra plasmid. Transformants were selected on
LB agar containing zeocin (60 𝜇gmL−1). Deletion of the
escN gene was confirmed using primers ESCN.verf5 and
ESCN.verf3, targeting regions flanking this gene (Table 2).
For complementation, the plasmid pEscN (pACYC184 vector
carrying the escN gene) was electroporated into 1711-4 ΔescN
and transformants were selected on LB agar containing
chloramphenicol (30 𝜇gmL−1) [6].
2.4. Fluorescent-Actin Staining (FAS) Test in HeLa Cells. This
test allows an indirect evaluation of the pathogen’s ability to
induce A/E lesions evidenced by actin nucleation underneath
the site of intimate bacterium-enterocyte interaction [23].
Bacteria were grown in 5mL of LB broth for approximately
18 h, in ambient air, at 37∘C. Caco-2 cells were grown in
24-well plates (Corning) containing glass coverslips. They
were cultivated inDulbecco’smodifiedEagle’sminimal essen-
tial medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) in a 5% CO
2
atmosphere at 36 ± 1∘C. Cells were
grown up to 80% confluence. Cells were then washed three
times with phosphate-buffered saline (PBS) before DMEM
supplemented with 10% FBS containing 40 𝜇L of bacterial
suspension (∼108 CFUmL−1) was added. Three hours after
infection, cells were washed with PBS before they were fixed
with 3% formaldehyde and permeabilized with 1% Triton
X-100 for 4min. Cells were washed with PBS and then
incubated with PBS containing 5𝜇g/mL fluorescein isoth-
iocyanate (FITC)-conjugated phalloidin (Sigma-Aldrich) for
20min in a dark chamber. Cells were then washed three
timeswith PBS every 10min. Coverslips were removed, dried,
and placed inverted onto glass slides containing 10 𝜇L of
80% glycerol in PBS. Preparations were examined under
fluorescence microscopy.
2.5. Infection of Caco-2 Cell Monolayers. Monolayers of
postconfluent and differentiated Caco-2 cells were infected
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Table 1: Bacterial strains and plasmids used in this study.
Genotype and characteristics Genotype and characteristics Source/reference
1711-4 aEPEC O51:H40; wild-type Gomes et al., 2004 [21]
1711-4 ΔescN escN::zeo (Zeor) This study
1711-4 ΔescN (pEscN) 1711-4 ΔescN carrying pEscN (Zeor, Clor) This study
pEscN pACYC184 carrying the escN gene from tEPEC E2348/69 strain Gauthier et al., 2003 [6]
pKOBEG-Aprar Derivative (Aprar) of pKOBEG plasmid encoding the 𝜆 phage red operon Chaveroche et al., 2000 [22]
MC4160-malTΔ224::zeo-(F+) Source of zeocin cassette Gift from J. M. Ghigo
rMeans that the strain is resistant to that antibiotic.
Table 2: Primers used for construction and verification of mutation.
Designation Primer sequence
Allelic exchange
ESCN.zeo-5 5󸀠-TGGGAATAATATCGAACTTAAAGTATTAGGAACGGTAAATGGTCATCGCTTGCATTAGAAAG-3󸀠
ESCN.zeo-3 5󸀠-CGCTCTGCTTTTACGAATAGATAAAATTCTGTCCAACATATTCAGAATGATGCAGAGATGTAAG-3󸀠
Verification
ESCN.verf-5 5󸀠-TCAGGCGCTATGTGAAGAAA-3󸀠
ESCN.verf-3 5󸀠-TACGCCTGCTTAGAGGCAAT-3󸀠
aUnderlined bases correspond to 5󸀠 and 3󸀠 regions of the Sh ble gene, which encodes zeocin resistance.
with ∼1×107 colony forming units (CFU) mL−1 in each well
of a 6-well cell culture plate. The number of cell-associated
bacteria was determined three hours after infection. Cells
were washed with phosphate-buffered saline pH 7.2 (PBS)
before they were lysed with 1% (v/v) Triton X-100. Bacterial
suspensions were plated on LB agar to determine the number
of CFU. Bacterial invasion and persistence were assessed
using gentamicin (100 and 10 𝜇g mL−1, resp.) to kill extracel-
lular bacteria before eukaryotic cell lysis for determination of
the number of viable bacteria. All tests were performed twice
in triplicate. The percentage of bacteria recovered after 48 h
(persistence index) was calculated taking the number of CFU
at three hours as 100% [15].
2.6. Rabbit Ligated Ileal Loop Model. Prior to the assays,
New Zealand White rabbits (weighing 1.8 to 2.5 kg and
4 to 8 weeks of age) were examined for the presence of
A/E lesion-producing E. coli by PCR using primers that
identify the eae gene [24]. All bacterial strains were tested
in three animals. Rabbits were fed only 10% (w/v) glucose
solution for 48 h prior to the test. Rabbits were anesthetized
with an intramuscular injection of Telazol (Fort Dodge
Animal Health, Iowa, USA) (0.2mL kg−1) and sedated with
Nilperidol (0.3mL kg−1, Crista´lia, Sa˜o Paulo, Brazil). Anti-
sepsis with 70% (v/v) ethanol was performed after shaving
the abdomen. The mid-ileum was exposed by a midline
laparotomy, and through a small incision made on the ileum
wall, the distal portionwas gentlywashed using a syringewith
sterile saline to minimize the presence of luminal feces and
resident microbiota. Immediately afterwards, five separated
ileum segments, measuring 5 cm long and 3 cm apart, were
constructed by ligatures, and 0.3mL of a bacterial suspension
(1 × 108 CFUmL−1) in sterile LB broth was injected into
each ligated loop using a 25-gauge needle. The ileum was
then returned to the abdominal cavity, and the peritoneal
membrane and the abdominal wall were sutured. Animals
were kept fasting for eight or 24 h and then were sacrificed
with 3% (w/v) pentobarbital and zolazepam hydrochloride
(0.4mL kg−1). Ileal fragments including the whole intestinal
wall were excised and fixed in 3% (w/v) glutaraldehyde
in 0.1M sodium cacodylate buffer, pH 7.2, for electron
microscopy procedures.
2.7. Transmission Electron Microscopy (TEM). After fixing
with 2.5% (v/v) glutaraldehyde for 24 h at 4∘C, the ileal
fragments were rinsed with 0.1M cacodylate buffer, pH 7.4,
and postfixed in 1% (w/v) osmium tetroxide. Specimens were
then exposed to a graded ethanol series and to propylene
oxide. After embedding in Epon resin and polymerization
at 60∘C for 48 h, ultrathin sections were stained with 2.0%
(w/v) aqueous uranyl acetate and 2.5% (w/v) lead citrate. The
specimenswere then examined under a transmission electron
microscope (JEOL 1200 EX II) at 80 kV.
2.8. Histopathological Analyses. Transverse segments of rab-
bit ileum were fixed in buffered formalin before they were
processed and embedded in paraffin. Sections were stained
with hematoxylin-eosin before they were examined by a
pathologist without previous knowledge of the details of the
rabbit ileal loop experiments. Microscopy was carried out
with a Zeiss microscope model Axio Lab.A1.
2.9. Bacterial Translocation Assays. Prior to the assays,
adult female Wistar-EPM rats weighing 200–250 g (𝑛 =
11/bacterial strain) were examined for the presence of A/E
lesion-producing E. coli as described above. Animals received
rat chow and water ad libitum, and 24 h before the exper-
iments, animals were fasting but had free access to water.
During the experiments, animals were kept under anesthesia
(xylazine hydrochloride plus ketamine hydrochloride (1 : 4),
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Figure 1: Lack of T3SS renders aEPEC 1711-4 unable to aggregate actin in HeLa cells and association with Caco-2 cells is decreased in the
absence of T3SS. The ability of the wild-type strain 1711-4, its isogenic mutant deficient in escN, and the complemented mutant 1711-4 ΔescN
(pEscN) as well to promote actin aggregation in vitro (evidence of A/E lesion formation) was examined by FAS. For actin accumulation,
cells were stained with fluorescein isothiocyanate (FITC)-conjugated phalloidin (green), and bacterial (white arrow) and HeLa cell DNA was
stained with DAPI (blue). No actin nucleation was observed with 1711-4 ΔescN mutant, whereas the ability of the complemented mutant
to induce actin nucleation was restored (white arrowhead) (Figure 1(a)). Bacterial association was evaluated six hours after infection of
differentiated Caco-2 cells. The number of viable bacteria recovered from cells infected with 1711-4 ΔescN mutant (∼4.0×104 CFU/well) was
significantly lower compared with the wild-type strain (1.2 × 107 CFU/well) (𝑃 < 0.05). ∗The association capacity of the escN mutant was
restored in the 1711-4 ΔescN (pEscN) complemented strain and no statistically significant difference was observed when compared to the
wild-type strain aEPEC 1711-4 (𝑃 > 0.05) (Figure 1(b)).
0.1mL per 100 g bodyweight, intramuscular). After antisepsis
with 70% (v/v) ethanol and midline laparotomy, the terminal
ileum was ligated, the second portion of the duodenum
was repaired, and an oroduodenal catheter was inserted.
Subsequently, an inoculum of 1010 CFUmL−1 (5mL per
100 g body weight) was injected through the catheter and
confined to the entire small bowel segment by the duodenum
ligature. In six animals, saline was used instead of bacterial
suspension (sham). The abdominal wall was closed with
stitches after catheter removal. Sodium dipyrone (25mg per
kg body weight) was used for analgesia. After a period
of two hours, animals were again subjected to laparotomy
under anesthesia and samples were collected for analysis: one
milliliter of blood from the inferior cava vein, MLN, spleen,
and liver. Upon completion of the procedures, the animals
were sacrificed by sectioning the aorta, still under anesthesia.
Organs were weighed separately, crushed, macerated, and
suspended in sterile saline, and the filtrate was plated on
MacConkey agar to determine the number of translocated
bacteria. Twenty-four hours after incubation in ambient air
at 37∘C, the translocated bacteria in the plate were counted
and CFU/g/compartment were determined [25].
2.10. Statistical Analyses. Data were analyzed using Prism
program version 5.03 from GraphPad Software. Analysis of
variance (ANOVA)with Bonferroni post hoc test was applied
to evaluate all results. ANOVA and Fisher’s exact test were
used for analysis of the BT results.
3. Results
3.1. T3SS Mutant of aEPEC 1711-4 (1711-4 ΔescN) Is Unable to
Cause A/E Lesion and Is Required for Efficient Association of
aEPEC 1711-4 with Differentiated Caco-2 Cells In Vitro While
escN Complementation RestoresThese Features. The ability of
thewild-type strain 1711-4, its T3SS isogenicmutant (deficient
in escN), and complementedmutant 1711-4 ΔescN (pEscN) as
well to cause A/E lesions in vitrowas evaluated using the FAS
test. As expected and in contrast to the wild-type strain, no
actin nucleation was observed with the 1711-4 ΔescN mutant,
whereas the ability of the complemented mutant to induce
actin nucleation was restored as in Figure 1(a). Although we
have obtained the same results in Caco-2 cells, the presence
of microvilli in polarized cells hampered the generation of a
sharp image.
Bacterial association was evaluated three hours after
infection ofCaco-2 cells.Thenumber of viable bacteria recov-
ered from cells infected with the 1711-4 ΔescN mutant was
on average 4 × 104 CFU/well. This number was significantly
lower (𝑃 < 0.05) than that obtained with the wild-type strain
(1.2 × 107 CFU/well). The association capacity of the escN
mutant was restored in the 1711-4 ΔescN (pEscN) comple-
mented strain, with no statistically significant difference (𝑃 >
0.05) when compared to the wild-type strain Figure 1(b).
3.2. T3SS Mutant (1711-4 ΔescN) Has a Decreased Ability to
Invade Differentiated Caco-2 Cells but Persist Intracellularly.
Gentamicin protection assays were used to evaluate bacterial
invasion, while persistence was evaluated 48 h after infection.
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Figure 2: TEM images of rabbit ileal loops infected with aEPEC 1711-4, an isogenic T3SS-mutant or non-pathogenic E. coliHS. (a) wild-type
strain at 8 h after infection; (b), (c), and (d)—1711-4 wild-type strain at 24 h after infection. Note an epithelial disorganization at 24 h after
infection (c) and (d) in tissue infected with aEPEC 1711-4 strain but not 1711-4 ΔescN (e) or nonpathogenic E. coli strain HS (f). Of note,
aEPEC 1711-4 was detected inside an enterocyte at 8 h (a) and 24 h (b) after infection (black arrowheads). Note actin accumulation leading to
pedestal formation (black arrow) (c).
Table 3: Intracellular bacteria at three and 48 hours after infection of Caco-2 cells.
Strain Number of intracellular bacteriaat 3 hours (mean ± SD)
Number of intracellular bacteria
at 48 hours (mean ± SD)
Mean bacterial
persistence index
1711-4 WT 41,666 ± 16,093.5 3,333 ± 1,310.9 7.9%
1711-4 ΔescN 1350 ± 129.1 433 ± 110.1 32.1%
1711-4 ΔescN (pEscN) 37,500 ± 3,535.5 3,266 ± 503.3 8.7%
The mean number of CFU/well recovered from Caco-2 cells
infected with the wild-type strain was approximately 30-fold
higher than that observed with the 1711-4 ΔescN mutant. In
addition, the mean CFU number obtained with the comple-
mented mutant 1711-4 ΔescN (pEscN) was approximately 27-
fold higher than that observed with the 1711-4 ΔescN mutant
(Table 3). These differences were statistically significant (𝑃 <
0.05).
For bacterial persistence evaluation, monolayers were
washed with PBS three hours after infection and incubated
with DMEM containing gentamicin (10 𝜇gmL−1) to elimi-
nate extracellular bacteria. The number of CFU recovered
48 h after infection with the 1711-4ΔescN mutant was approx-
imately 7-fold lower (𝑃 < 0.05) than that observed with the
wild-type strain, while the complemented mutant 1711 ΔescN
(pEscN) showed restored ability to persist inside enterocytes,
which did not significantly differ compared to the wild-type
strain (𝑃 > 0.05). The persistence rate was 7.9% for wild-type
strain 1711-4, 32.1% for the 1711-4 ΔescN mutant, and 8.7% for
the complemented 1711 ΔescN mutant (Table 3).
3.3. T3SS Is Necessary for Enterocyte A/E Lesion Formation
and Invasion in the Rabbit Ligated Ileal Loop Model In Vivo.
To evaluate the interaction of aEPEC 1711-4 with intestinal
mucosa in vivo, we used the rabbit ligated ileal loop model.
Eight or 24 h after infection, wild-type strain 1711-4 was
observed intimately attached to the intestinal mucosa with
effacement of the microvilli and pedestal formation, which
are features of A/E lesions (Figure 2). Eight or 24 h after
infection, the wild-type strain was also detected inside ente-
rocytes (Figures 2(a) and 2(b)). An epithelial disorganization
was observed 24 h after infection with the wild-type strain
(Figures 2(c) and 2(d)). No A/E lesions or invasion was
observed with the 1711-4 ΔescN mutant (Figure 2(e)) or the
nonpathogenic E. coli strain HS (Figure 2(f)).
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Figure 3: Histopathological analyses of the H&E-stained infected rabbit ileum sections. Squares indicate areas magnified in (Figure 3 (a1),
(b1), and (c1)). (a) and (a1)—Ileal loop infected with aEPEC 1711-4; (b) and (b1) ileal loop infected with 1711-4 ΔescN; (c) and (c1) ileal loop
infectedwithE. coliHS.Note intense intraluminal polymorphonuclear leukocytes (PMN) infiltrate, red arrow, in (Figure 3(a)). Notemoderate
PMN tissue infiltration in (a1) and (b1).
3.4. aEPEC 1711-4 Stimulates an Acute PMN Infiltrate in
the Rabbit Ileal Loop Model. Sections of the ileum infected
with the wild-type aEPEC strain 1711-4 showed a moderate
intraepithelial polymorphonuclear leukocytes (PMN) infil-
trate, a large number of intraluminal PMN, and intraluminal
bleeding (Figure 3(a)-(a1)).The ileum infectedwith the 1711-4
ΔescN had an intraepithelial and intraluminal PMN infiltrate
but to a lesser extent than that observed with the wild-type
strain (Figure 3(b)-(b1)). In contrast, the ileum infected with
the nonpathogenic strain HS showed a discrete polymor-
phonuclear infiltration (Figure 3(c)-(c1)).
3.5. T3SS Is Necessary for Efficient In Vivo Translocation
of aEPEC 1711-4 in the Rat Model. The Most striking
difference—3 log
10
—was observed in the number of CFU
recovered from MLN of animals infected with wild-type
strain 1711-4 when compared to that recovered from animals
infected with the T3SS-deficient mutant (1711-4 ΔescN), but
marked reduction in the CFU number was also observed in
spleen and liver, since this mutant was not recovered even
from these organs (𝑃 < 0.05) (Figure 4).
4. Discussion
In this study, we analyzed the ability of aEPEC 1711-4 as well
as its isogenic mutant deficient in T3SS to adhere to, invade,
and persist inside intestinal Caco-2 cells in vitro. We also
evaluated the ability of these strains to invade and elicit an
inflammatory infiltrate in a rabbit ligated ileal loop model in
vivo and to translocate through the intestinal mucosa in a rat
model.
During in vitro or in vivo interactions, aEPEC strains
translocate effector proteins into enterocytes through a T3SS,
resulting in the formation of A/E lesions [26]. According
to Gauthier et al., 2003, the EscN protein functions as an
ATPase, whose absence prevents T3SS assembly, blocking
translocation of some structural and effector proteins into the
eukaryotic target cell [6]. Our results demonstrated that the
1711-4 escN mutant was unable to cause A/E lesion in HeLa
cells and to adhere effectively to Caco-2 cells thus indicating
that T3SS contributes to aEPEC 1711-4 adhesion. This was
expected since Tir uses T3SS to reach the eukaryotic cell cyto-
plasm before inserting into the host cell membrane to serve
as an intimin receptor [8]. However, some intimin subtypes
have alternative receptors in the eukaryotic membrane [27–
29] and flagella also play a role in bacterial adhesion [15, 16,
30]. These previous findings may explain why escN deletion
decreased but did not abolish the ability of aEPEC 1711-4 to
adhere to Caco-2 cells in vitro. Additionally, previous studies
conducted in our laboratory have demonstrated that aEPEC
strains can produce several fimbrial adhesion structures,
which could contribute to the adherence process at least in
epithelial cells in vitro [31].
Considering that aEPEC 1711-4 is able to invade Caco-2
cells and persist and induce IL-8 production, IL-8 secretion
by rabbit enterocytes could have driven the polymorphonu-
clear infiltration observed in ileal loops infected with aEPEC
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Figure 4: Bacterial translocation assays. Bacterial recovery after
BT in mesenteric lymph node (MLN), spleen, and liver 2 h after
infection. Statistically significant differences (∗) were observed
between aEPEC 1711-4 and 1711-4 ΔescN in all compartments (𝑃 <
0.05). Bacteria were not detected in sham animals. HS strain was
only detected in MLN.
1711-4 but not with the nonpathogenic E. coli HS. On the
other hand, some authors reported that an escN deficient
mutant derived from the tEPEC prototype strain E2348/69
was able to induce very high levels of IL-8 in a flagella-
dependent pathway [32, 33]. Consequently, we would expect
a more exuberant PMN infiltrate in ileal loops infected
with the 1711-4 ΔescN strain, but surprisingly the more
pronounced intraepithelial and intraluminal PMN infiltrates
were observed with the wild-type strain. These data taken
together indicate that IL-8 production by enterocytes may
not be the main factor determining epithelial infiltration by
PMN during aEPEC infection in vivo. Another CXC-type
chemokine, such as CXCL1 or CXCL5 [34, 35] known to
be produced by enterocytes and to have their transcription
driven by NF𝜅B signaling pathways triggered via toll-like
receptors, may be more important in neutrophil recruitment
in the rabbit ileal loop model.
Although the total CFU of the escN mutant detected
in the intracellular compartment at 48 h was reduced when
compared to the wild-type 1711-4 strain, the persistence index
(the percentage of intracellular bacteria detected at 48 h)
indicated that the 1711-4 ΔescN mutant had an increased
capacity to persist inside Caco-2 cells (32.1%). Possibly a
nonfunctional T3SS reduces the induction of nitric oxide
synthase (iNOS) allowingmore efficient bacterial persistence,
suggesting that iNOS induction may be the result of one
or more T3SS-dependent effectors [36]. Persistence may be
essential to establish the carrier state, allowing colonization of
other parts of the intestinal epithelium by bacteria that escape
from infected enterocytes or allowing bacteria to go unde-
tected by phagocytes and antibodies. aEPEC location inside
vacuoles with pedestal formation, as demonstrated in HeLa
and Caco-2 cells may be another protective factor allowing
intracellular persistence [37]. Several studies have shown that
E. coli is the most commonly isolated pathogen in bacterial
translocation events [38–41]. Moreover, some authors have
demonstrated the occurrence of bacterial translocation in
patients who developed sepsis after surgery [39]. It has been
shown that a specific E. coli strain isolated from a fatal
case of human hemorrhagic pancreatitis was more efficiently
translocated to MLNs, blood, and peritoneal fluid [42].
To date, no cases of bacteremia due to EPEC have been
described in humans, but strains harboring the eae gene
have been detected in E. coli cultivated from bacteremic
neonatal calves [43]. In previous studies by our group, we
have shown that some aEPEC strains have the potential to
invade and persist in enterocytes (Caco-2 and T84 cells)
in vitro [16] and to translocate in the rat model [17]. In
this study, we demonstrated by electron microscopy that
the 1711-4 strain was able to colonize and to form A/E lesions
in rabbit intestinal cells in the ileal loop model in vivo. This
event was not observedwith the escN-deficientmutant.These
results suggest the involvement of T3SS in the translocation
event in vivo. Liberatore et al. demonstrated that EPEC are
able to translocate through the small bowel epithelium and
reach not only the MLN but the spleen and the liver as
well in a rat model. In this model, translocation of wild-
type aEPEC 1711-4 has also been associated with damage to
mesenteric microcirculation and hypoperfusion in the liver,
small intestine, and kidneys [17]. We demonstrated in this
study that a functional T3SS is necessary for efficient bacterial
translocation, since a decreased number of bacteria were
recovered from the liver and spleen of rats infected with
the 1711-4 escN mutant. Martinez-Argudo et al. reported
that T3SS is required for inducing loss of intestinal barrier
function and allowing translocation of Salmonella enterica
strains through M cells [44]. The effector proteins injected
via the T3SS that could contribute to driving the translocation
events need to be characterized. Although findings in animal
models should be extrapolated to humans with caution, our
results indicate that aEPEC, an infectious agent theoretically
restricted to the intestinal mucosa, has the potential to cross
the intestinal barrier under overgrowth conditions which
can occur in many clinical situations, such as immunosup-
pression, antibiotic therapy, biliary obstruction, and other
processes that cause changes in the intestinal microbiota.
5. Conclusion
Research carried out with in vitro and in vivo models have
added to our understanding of how bacteria interact with
and modify host cells functions leading to the establishment
of disease. Our findings indicate that the full virulence
potential of aEPEC 1711-4 depends on a functional T3SS,
which contributes to efficient adhesion/invasion in vitro and
in vivo and to bacterial translocation to extraintestinal sites.
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